Literature DB >> 11170639

Current and novel approaches to the drug treatment of schizophrenia.

M Rowley1, L J Bristow, P H Hutson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170639     DOI: 10.1021/jm0002432

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  12 in total

Review 1.  Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?

Authors:  Hans H Schiffer
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

2.  Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.

Authors:  Xingyu Lin; Xi-Ping Huang; Gang Chen; Ryan Whaley; Shiming Peng; Yanli Wang; Guoliang Zhang; Simon X Wang; Shaohui Wang; Bryan L Roth; Niu Huang
Journal:  J Med Chem       Date:  2012-06-19       Impact factor: 7.446

3.  Selectivity mechanism of phosphodiesterase isoform inhibitor through in silico investigations.

Authors:  Junhao Huang; Baichun Hu; Ziqi Xu; Yunxia Ye; Huibin Wang; Shuxiang Wang; Zhilong Liu; Jian Wang
Journal:  J Mol Model       Date:  2021-12-14       Impact factor: 1.810

Review 4.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

5.  FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia.

Authors:  Frank Boeckler; Holger Russig; Weining Zhang; Stefan Löber; John Schetz; Harald Hübner; Boris Ferger; Peter Gmeiner; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

6.  Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.

Authors:  A Newman-Tancredi; J-M Rivet; D Cussac; M Touzard; C Chaput; L Marini; M J Millan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-08-16       Impact factor: 3.000

7.  mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task.

Authors:  Amber L LaCrosse; Brian T Burrows; Rachel M Angulo; Phoebe R Conrad; Sarah M Himes; Nordia Mathews; Scott A Wegner; Sara B Taylor; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2014-06-29       Impact factor: 4.530

Review 8.  Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Front Behav Neurosci       Date:  2014-03-06       Impact factor: 3.558

9.  Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder.

Authors:  Delia Bishara; David Taylor
Journal:  Neuropsychiatr Dis Treat       Date:  2009-10-12       Impact factor: 2.570

10.  Chronic zinc exposure decreases the surface expression of NR2A-containing NMDA receptors in cultured hippocampal neurons.

Authors:  Jia Zhu; Chong-Yu Shao; Wei Yang; Xiao-Min Zhang; Zhen-Yong Wu; Liang Zhou; Xin-Xin Wang; Yun-Hong Li; Jun Xia; Jian-Hong Luo; Ying Shen
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.